[Progress in immunodiagnosis and chemotherapy of protozoan infections].
D000562:Amebiasis / Q000188:drug therapy / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000276:immunology; D001404:Babesiosis / Q000188:drug therapy; D002738:Chloroquine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005873:Giardiasis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy; D008288:Malaria / Q000188:drug therapy / Q000276:immunology; D015767:Mefloquine; D011010:Pneumocystis / Q000276:immunology; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011319:Primaquine / Q000627:therapeutic use; D011528:Protozoan Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012698:Serologic Tests; D013413:Sulfadoxine / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy / Q000276:immunology; D014352:Trypanosomiasis / Q000188:drug therapy
D000906:Antibodies; D011804:Quinolines; D013413:Sulfadoxine; D002738:Chloroquine; D011803:Quinine; D013752:Tetracycline; D011319:Primaquine; D015767:Mefloquine; D011739:Pyrimethamine
Fortschritte in der Immundiagnostik und Chemotherapie der Protozoeninfektionen.